{"latest_checked": "2026-07-29T22:11:07.860409+00:00", "coverage_count": 5079, "recent_count": 14, "transaction_limit": 160, "filters": {"q": "", "ticker": "PALI", "sector": "", "industry": "", "side": "", "start": "2026-06-15", "end": "2026-07-30"}, "summary": {"total": 14, "acquisition_count": 9, "disposal_count": 5, "acquisition_value": 250275.1, "acquisition_value_label": "$250.3K", "disposal_value": 409878.9672, "disposal_value_label": "$409.9K", "net_value": -159603.8672, "net_value_label": "$-159.6K", "flow_tone": "negative", "largest_value_label": "$303.3K", "top_sector": "Healthcare", "window_label": "15 Jun 2026 to 30 Jul 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 14, "value": "660154.0672", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$660.2K"}], "days": [{"transaction_date": "2026-07-01", "acquisitions": 1, "disposals": 0, "total": 1, "bar_width": 20.0}, {"transaction_date": "2026-07-02", "acquisitions": 1, "disposals": 0, "total": 1, "bar_width": 20.0}, {"transaction_date": "2026-07-06", "acquisitions": 3, "disposals": 2, "total": 5, "bar_width": 100.0}, {"transaction_date": "2026-07-07", "acquisitions": 2, "disposals": 3, "total": 5, "bar_width": 100.0}, {"transaction_date": "2026-07-08", "acquisitions": 1, "disposals": 0, "total": 1, "bar_width": 20.0}, {"transaction_date": "2026-07-09", "acquisitions": 1, "disposals": 0, "total": 1, "bar_width": 20.0}], "side_mix": {"acquisitions": 9, "disposals": 5, "acquisition_share": 64.3, "disposal_share": 35.7}}, "company_flows": [{"symbol": "PALI", "name": "Palisade Bio Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-09", "acquisitions": 7, "disposals": 5, "acquired_value": 250275.1, "acquired_value_label": "$250.3K", "disposed_value": 409878.9672, "disposed_value_label": "$409.9K", "net_value": -159603.8672, "net_value_label": "$-159.6K", "acquisition_share": 58.3, "disposal_share": 41.7, "detail_url": "https://sharemaestro.com/insider-activity/company/pali/", "research_links": {"chart": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/", "report": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/report/", "factor": "/factors/ticker/4e57039b-4e7e-450f-85f7-d0d4483c41ad/"}}], "company_overview": [{"symbol": "PALI", "name": "Palisade Bio Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-09", "filings": 14, "acquisitions": 9, "disposals": 5, "acquired_value": 250275.1, "acquired_value_label": "$250.3K", "disposed_value": 409878.9672, "disposed_value_label": "$409.9K", "net_value": -159603.8672, "net_value_label": "$-159.6K", "acquisition_share": 64.3, "disposal_share": 35.7, "tone": "Net acquisition", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/pali/", "research_links": {"chart": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/", "report": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/report/", "factor": "/factors/ticker/4e57039b-4e7e-450f-85f7-d0d4483c41ad/"}}], "transactions": [{"symbol": "PALI", "name": "Palisade Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-09", "executive": "BALTERA, ROBERT JR.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 25000.0, "share_price": 1.956, "transaction_value": 48900.0, "fetched_at": "2026-07-29T22:01:53.140960+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pali/", "research_links": {"chart": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/", "report": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/report/", "factor": "/factors/ticker/4e57039b-4e7e-450f-85f7-d0d4483c41ad/"}}, {"symbol": "PALI", "name": "Palisade Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-08", "executive": "BALTERA, ROBERT JR.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 20000.0, "share_price": 1.9899, "transaction_value": 39798.0, "fetched_at": "2026-07-29T22:01:53.144377+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pali/", "research_links": {"chart": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/", "report": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/report/", "factor": "/factors/ticker/4e57039b-4e7e-450f-85f7-d0d4483c41ad/"}}, {"symbol": "PALI", "name": "Palisade Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "FINLEY, JOHN DAVID", "executive_title": "Director, CEO, CFO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 146798.0, "share_price": 2.0664, "transaction_value": 303343.3872, "fetched_at": "2026-07-28T10:51:51.360612+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pali/", "research_links": {"chart": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/", "report": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/report/", "factor": "/factors/ticker/4e57039b-4e7e-450f-85f7-d0d4483c41ad/"}}, {"symbol": "PALI", "name": "Palisade Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "JONES, MITCHELL LAWRENCE", "executive_title": "Chief Medical Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 51880.0, "share_price": 2.0535, "transaction_value": 106535.58, "fetched_at": "2026-07-28T10:51:51.367125+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pali/", "research_links": {"chart": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/", "report": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/report/", "factor": "/factors/ticker/4e57039b-4e7e-450f-85f7-d0d4483c41ad/"}}, {"symbol": "PALI", "name": "Palisade Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "BALTERA, ROBERT JR.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 30000.0, "share_price": 2.0348, "transaction_value": 61044.0, "fetched_at": "2026-07-28T10:51:51.365232+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pali/", "research_links": {"chart": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/", "report": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/report/", "factor": "/factors/ticker/4e57039b-4e7e-450f-85f7-d0d4483c41ad/"}}, {"symbol": "PALI", "name": "Palisade Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "FINLEY, JOHN DAVID", "executive_title": "Director, CEO, CFO", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 133.0, "share_price": 0.7, "transaction_value": 93.1, "fetched_at": "2026-07-28T10:51:51.369133+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pali/", "research_links": {"chart": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/", "report": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/report/", "factor": "/factors/ticker/4e57039b-4e7e-450f-85f7-d0d4483c41ad/"}}, {"symbol": "PALI", "name": "Palisade Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "FINLEY, JOHN DAVID", "executive_title": "Director, CEO, CFO", "security_type": "Series 2 Common Stock Purchase Warrant", "side_code": "D", "side": "Disposal", "shares": 133.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-28T10:51:51.363103+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pali/", "research_links": {"chart": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/", "report": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/report/", "factor": "/factors/ticker/4e57039b-4e7e-450f-85f7-d0d4483c41ad/"}}, {"symbol": "PALI", "name": "Palisade Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "FINLEY, JOHN DAVID", "executive_title": "Director, CEO, CFO", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 335167.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-24T11:08:24.596834+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pali/", "research_links": {"chart": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/", "report": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/report/", "factor": "/factors/ticker/4e57039b-4e7e-450f-85f7-d0d4483c41ad/"}}, {"symbol": "PALI", "name": "Palisade Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "JONES, MITCHELL LAWRENCE", "executive_title": "Chief Medical Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 131167.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-24T11:08:24.591745+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pali/", "research_links": {"chart": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/", "report": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/report/", "factor": "/factors/ticker/4e57039b-4e7e-450f-85f7-d0d4483c41ad/"}}, {"symbol": "PALI", "name": "Palisade Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "BALTERA, ROBERT JR.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 20000.0, "share_price": 2.052, "transaction_value": 41040.0, "fetched_at": "2026-07-24T11:08:24.594325+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pali/", "research_links": {"chart": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/", "report": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/report/", "factor": "/factors/ticker/4e57039b-4e7e-450f-85f7-d0d4483c41ad/"}}, {"symbol": "PALI", "name": "Palisade Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "FINLEY, JOHN DAVID", "executive_title": "Director, CEO, CFO", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 335167.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-24T11:08:24.588968+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pali/", "research_links": {"chart": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/", "report": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/report/", "factor": "/factors/ticker/4e57039b-4e7e-450f-85f7-d0d4483c41ad/"}}, {"symbol": "PALI", "name": "Palisade Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "JONES, MITCHELL LAWRENCE", "executive_title": "Chief Medical Officer", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 131167.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-24T11:08:24.599384+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pali/", "research_links": {"chart": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/", "report": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/report/", "factor": "/factors/ticker/4e57039b-4e7e-450f-85f7-d0d4483c41ad/"}}, {"symbol": "PALI", "name": "Palisade Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "BALTERA, ROBERT JR.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 10000.0, "share_price": 1.98, "transaction_value": 19800.0, "fetched_at": "2026-07-22T21:57:31.398979+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pali/", "research_links": {"chart": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/", "report": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/report/", "factor": "/factors/ticker/4e57039b-4e7e-450f-85f7-d0d4483c41ad/"}}, {"symbol": "PALI", "name": "Palisade Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "BALTERA, ROBERT JR.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 20000.0, "share_price": 1.98, "transaction_value": 39600.0, "fetched_at": "2026-07-22T21:57:31.401083+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pali/", "research_links": {"chart": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/", "report": "/terminal/4e57039b-4e7e-450f-85f7-d0d4483c41ad/report/", "factor": "/factors/ticker/4e57039b-4e7e-450f-85f7-d0d4483c41ad/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}